- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Drug Delivery Systems
BioDelivery Sciences International Inc
+ Add to WatchlistBDSI:US
4.3400 USD 0.1900 4.19%As of 17:20:00 ET on 05/21/2013.
Snapshot for BioDelivery Sciences International Inc (BDSI)
| Open: | 4.5000 | Day's Range: | 4.3000 - 4.5000 | Volume: | 295,239 |
|---|---|---|---|---|---|
| Previous Close: | 4.5300 | 52wk Range: | 3.1200 - 6.8900 | 1-Yr Rtn: | +3.33% |
Key Statistics for BDSI
| Current P/E Ratio (ttm) | 16.6923 |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | 1.0237 |
| Earnings Per Share (ttm) | 0.2600 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 164.97 |
| Shares Outstanding (M) | 38.01 |
| 30 Day Average Volume | 242,882 |
| Price/Book (mrq) | 3.2682 |
| Price/Sale (ttm) | 2.3963 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/24/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BDSI
Company Profile & Key Executives for BDSI
BioDelivery Sciences International, Inc. is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology. The Company's technology is designed for a broad base of pharmaceuticals, vaccines, and over-the-counter drugs. Biodelivery's technology encapsulates the selected drug in a cochleate cylinder.
| Francis E O'Donnell JrChairman | Mark A SirgoPresident/CEO |
| James A McNultyCFO/Treasurer/Secretary | Andrew L FinnExec VP:Product Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BDSI News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page